Editorial: rapid disease progression in hepatitis delta-can we turn the tide? Authors' reply
- PMID: 31850577
- DOI: 10.1111/apt.15558
Editorial: rapid disease progression in hepatitis delta-can we turn the tide? Authors' reply
Comment on
-
Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia.Aliment Pharmacol Ther. 2020 Jan;51(1):158-166. doi: 10.1111/apt.15521. Epub 2019 Nov 13. Aliment Pharmacol Ther. 2020. PMID: 31721254
References
REFERENCES
-
- Sonneveld MJ, de Knegt RH. Editorial: rapid disease progression in hepatitis delta - can we turn the tide? Aliment Pharmacol Ther. 2020;51:172-173.
-
- Palom A, Rodríguez-Tajes S, Navascués CA, et al. Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia. Aliment Pharmacol Ther. 2020;51:158-166.
-
- Lampertico P, Agarwal K, Berg T, et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370-398.
-
- Béguelin C, Moradpour D, Sahli R, et al. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients. J Hepatol. 2017;66:297-303.
-
- Wranke A, Serrano BC, Heidrich B, et al. Antiviral treatment and liver-related complications in hepatitis delta. Hepatology. 2017;65:414-425.